Business Context and Reporting Period
Company: Omeros Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: May 10, 2011
Reporting Period: Three months ended March 31, 2011
Context: The filing announces the issuance of a press release detailing financial results for the quarter ended March 31, 2011. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) but does not contain the specific financial data within the body of the 8-K. Consequently, the following metrics are not available in the source text:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific numerical comparisons or descriptions of material changes versus the prior comparable period. It only confirms that results for the three months ended March 31, 2011, were announced.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release issued by the company but does not include the text of the commentary, guidance, or outlook.
Risks and Contingencies: No specific risks or contingencies are detailed in the provided text.
Unusual Items: No unusual items are described in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 10, 2011) to obtain actual revenue, net loss, and cash position figures.
- Verify the specific clinical trial progress or regulatory updates mentioned in the referenced press release, as the 8-K text itself contains no operational details.
- Confirm the company's cash runway and burn rate from the full press release, as liquidity is not stated in the 8-K summary.
- Check for any forward-looking statements or guidance revisions in the full press release text.